After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”)…
June 11, 2025 13:00 ET | Source: ONWARD Medical NV THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF…
PEMBROKE, Bermuda--(BUSINESS WIRE)--Gold Reserve Ltd. (TSX.V: GRZ) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that today the U.S. District…
June 05, 2025 16:30 ET | Source: Vireo Growth Inc. MINNEAPOLIS , June 05, 2025 (GLOBE NEWSWIRE) -- Vireo Growth…
Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA Evrysdi offers…
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced…